F2RL1 and Parkinson disease: It is worth noting that the same primary fibroblasts from patients with PD, when treated with 1-PPA in the conditions described above, documented a parallel decrease in expression not only of PAR2, but also of SerpinB3, which was previously found to play a relevant role in PAR2 synthesis and expression [26].